Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Esophageal Neoplasms 5 Barrett Esophagus 3 Pancreatic Neoplasms 2 Neoplasms 2 Lung Neoplasms 2 Stomach Neoplasms 1 Liver Neoplasms 1 Liver Cirrhosis 1 Fibrosis 1 Colorectal Neoplasms 1 Carcinoma, Hepatocellular 1 Carcinoma 1 Breath Test 1 Adenocarcinoma Of Esophagus 1

Interventions

Cisplatin 21 pembrolizumab 16 Gemcitabine 16 Paclitaxel 15 Radiotherapy 14 Carboplatin 14 Radiotherapy, Intensity-Modulated 13 Cyclophosphamide 9 Cetuximab 9 Magnetic Resonance Spectroscopy 8 Radiation 7 padeliporfin 6 Specimen Handling 6 Oxaliplatin 6 Fluorouracil 6 Drug Therapy 6 Docetaxel 6 Capecitabine 6 Bevacizumab 6 anlotinib 5 Nivolumab 5 Irinotecan 5 Erlotinib Hydrochloride 5 Celecoxib 5 poly ICLC 4 fludarabine 4 Standard of Care 4 Sorafenib 4 Leucovorin 4 Ipilimumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Carcinoma × Breath Tests × Clear all

NCT04419207 2022-04-20

Detecting Lung Cancer Based on Exhaled Breath

Peking University People's Hospital

Carcinoma, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡